Evidence map›Paper›PMID 17189182›Full record

ReviewMolecular cell2006

To die or not to die: a HAT trick.

Sandrine Tyteca, Gaëlle Legube, Didier Trouche

Abstract readReviewComment
PubMed Publisher
In one paragraph

Review in Molecular cell, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Build muscles and protect myelin.NeuroImmune pharmacology and therapeutics · 2024
    Review
  3. Article
  4. KAT8, lysine acetyltransferase 8, is required for adipocyte differentiation in vitro.Biochimica et biophysica acta. Molecular basis of disease · 2021
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. RNAi screening identifies KAT8 as a key molecule important for cancer cell survival.International journal of clinical and experimental pathology · 2013
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Sandrine TytecaLBME, CNRS and Université Paul Sabatier, 118 Route de Narbonne, 31062 Toulouse, France.
Gaëlle Legube
Didier Trouche

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this issue of Molecular Cell, two manuscripts (Sykes et al., 2006) propose that the decision to undergo apoptosis upon DNA damage is mediated through acetylation of p53 within its DNA-binding domain by MYST histone acetyltransferases.

Indexed as

Transcriptional ActivationAcetylationAnimalsApoptosisApoptosis Regulatory ProteinsCell CycleCyclin-Dependent Kinase Inhibitor p21Histone AcetyltransferasesHumansLysine Acetyltransferase 5p300-CBP Transcription FactorsProto-Oncogene ProteinsProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53Apoptosis Regulatory ProteinsBBC3 protein, humanCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21Histone AcetyltransferasesKAT5 protein, humanKAT8 protein, humanLysine Acetyltransferase 5MDM2 protein, humanp300-CBP Transcription FactorsProto-Oncogene ProteinsProto-Oncogene Proteins c-mdm2Tumor Suppressor Protein p53

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.